NCT06750952 2024-12-27
iTHYM
Sun Yat-sen University
Phase 2 Not yet recruiting
Clinical Trials
9 trialsNCT02420691 2020-10-30
Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02364076 2019-12-13
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Georgetown University
Phase 2 Unknown
NCT01364727 2019-04-16
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Stanford University
Phase 2 Completed
NCT03219554 2017-08-02
A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor
Samsung Medical Center
Phase 2 Unknown
NCT01312324 2016-04-20
Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
Samsung Medical Center
Phase 2 Completed
NCT01163552 2014-06-13
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
St. Luke's-Roosevelt Hospital Center
Phase 2 Completed
NCT00369889 2014-06-03
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
Indiana University
Phase 2 Completed
NCT00990535 2009-10-07
HIDONET
Federico II University
Phase 2 Completed